Efficacy of long-acting injectable antipsychotics in the treatment of bipolar disorder

被引：0
|
作者：
Lin, S. -K. [1 ]
机构：
[1] Taipei City Hosp, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2014年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-22-006
引用
收藏
页码：92 / 92
页数：1
相关论文
共 50 条
  • [21] The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
    Erbasan, V.
    Ekici, F.
    Ucak, E. F.
    Aydin, M.
    Altinbas, K.
    EUROPEAN PSYCHIATRY, 2023, 66 : S275 - S275
  • [22] Early use of long-acting injectable antipsychotics in bipolar disorder type I: An expert consensus
    Vieta, Eduard
    Tohen, Mauricio
    Mcintosh, Diane
    Kessing, Lars Vedel
    Sajatovic, Martha
    Mcintyre, Roger S.
    BIPOLAR DISORDERS, 2025, 27 (01) : 7 - 16
  • [23] Comparison of oral atypical Antipsychotics to a long-acting injectable atypical antipsychotic in patients with bipolar disorder
    Binder, C
    Fallu, A
    Yatham, LN
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 203S - 203S
  • [24] Long-Acting Injectable Antipsychotics in Bipolar Disorder: A 2-Year Prospective Cohort Study
    Spinola, Carla
    Neto, Daniel
    Pereira, Maria Emilia
    Gago, Joaquim
    NEUROPSYCHOBIOLOGY, 2018, 76 (01) : 49 - 50
  • [25] The effect of long-acting injectable antipsychotics on QRISK3 in patients with bipolar disorder and schizophrenia
    Erbasan, V.
    Ekici, F.
    Ucak, E. F.
    Aydin, M.
    Altinbas, K.
    EUROPEAN PSYCHIATRY, 2023, 66 : S275 - S275
  • [26] Both Typical and Atypical Long-Acting Injectable Antipsychotics in Bipolar Disorder: A Retrospective Chart Review
    Alpak, Gokay
    Demir, Bahadir
    Aksoy, Ihsan
    Kaya, Hilal
    Unal, Ahmet
    Bulbul, Feridun
    Savas, Haluk A.
    JOURNAL OF MOOD DISORDERS, 2014, 4 (01) : 20 - 25
  • [27] Risperidone Long-Acting Injectable Monotherapy in the Maintenance Treatment of Bipolar I Disorder
    Quiroz, Jorge A.
    Yatham, Lakshmi N.
    Palumbo, Joseph M.
    Karcher, Keith
    Kushner, Stuart
    Kusumakar, Vivek
    BIOLOGICAL PSYCHIATRY, 2010, 68 (02) : 156 - 162
  • [28] Comparison of Subjective Experiences between Patients with Schizophrenia and Bipolar Disorder Receiving Long-Acting Injectable Antipsychotics
    Lin, Shih-Ku
    Cnhen, Wen-Yin
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S203 - S203
  • [29] Efficacy and safety of long-acting injectable risperidone in maintenance phase of bipolar and schizoaffective disorder
    Benabarre, A.
    Castro, P.
    Sanchez-Moreno, J.
    Martinez-Aran, A.
    Salamero, M.
    Murru, A.
    Franco, C.
    Vieta, E.
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2009, 37 (03): : 143 - 147
  • [30] Long-acting injectable antipsychotics (LAIs) for maintenance treatment of bipolar and schizoaffective disorders: A systematic review
    Pacchiarotti, Isabella
    Tiihonen, Jari
    Kotzalidis, Georgios D.
    Verdolini, Norma
    Murru, Andrea
    Manuel Goikolea, Jose
    Valenti, Marc
    Aedo, Alberto
    Vieta, Eduard
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 (04) : 457 - 470
12345